Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD, Australia.
Adv Exp Med Biol. 2012;740:45-82. doi: 10.1007/978-94-007-2888-2_3.
Ca(2+) permeable ion channels and GPCRs linked to Ca(2+) release are important drug targets, with modulation of Ca(2+) signaling increasingly recognized as a valid therapeutic strategy in a range of diseases. The FLIPR is a high throughput imaging plate reader that has contributed substantially to drug discovery efforts and pharmacological characterization of receptors and ion channels coupled to Ca(2+). Now in its fourth generation, the FLIPR(TETRA) is an industry standard for high throughput Ca(2+) assays. With an increasing number of excitation LED banks and emission filter sets available; FLIPR Ca(2+) assays are becoming more versatile. This chapter describes general methods for establishing robust FLIPR Ca(2+) assays, incorporating practical aspects as well as suggestions for assay optimization, to guide the reader in the development and optimization of high throughput FLIPR assays for ion channels and GPCRs.
钙(Ca2+)通透性离子通道和与 Ca2+释放相关的 G 蛋白偶联受体是重要的药物靶点,Ca2+信号的调节已被广泛认为是多种疾病的有效治疗策略。FLIPR 是一种高通量成像板读数仪,它为药物发现工作和与 Ca2+偶联的受体和离子通道的药理学特性的描述做出了巨大贡献。现在已经发展到第四代,FLIPR(TETRA)是高通量 Ca2+测定的行业标准。随着越来越多的激发 LED 库和发射滤光片的出现,FLIPR Ca2+测定变得更加多样化。本章描述了建立稳健的 FLIPR Ca2+测定的一般方法,包括实际方面和测定优化建议,以指导读者开发和优化用于离子通道和 GPCR 的高通量 FLIPR 测定。